In the past seven trading days, the stock has dipped 11% after the United States Food and Drug Administration issued Form 483 with 8 observations for the company’s Pithampur manufacturing facilities
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
